NUAI News & Events

The deal priced below last closing price of $4.14. Northland and Texas Capital are acting as joint book running managers for the offering.

Northland Capital Markets is serving as lead book-running manager for the offering. Texas Capital Securities is acting as book-running manager for the offering.

New Era Energy & Digital announced that it has entered into a non-binding letter of intent, LOI, to form a joint venture for the development and financing of its Texas Critical Data Centers campus, TCDC, in West Texas. The joint venture will bring New Era together with Stream Data Centers, a Tier-1 U.S. data center development and operating platform, with equity capital provided by a third-party sponsor and arranger of institutional capital with significant experience in digital infrastructure and energy investments.

Reports that the easing chokehold on a critical global energy supply that is the Straight of Hormuz helped sentiment recover on Monday as WTI Crude Oil prices fell over $7 below $93 per barrel and major indices bounced for the first time in five trading sessions.   Some of the higher-beta areas of the market outperformed and even Energy names traded firmer, while the more defensively oriented consumer staples underperformed.  Tech Hardware and Semis were especially strong, with names like Sandiskup 6.4% and Micronup 3.7% approaching 2026 highs.In the opening hour of the evening session, sentiment is less exuberant - both S&P 500 and Nasdaq 100 futures are down by over a decimal.   WTI has also come off its Monday lows to trade above $94.50, while precious metals are seeing little volatility as USD rally appears to have stalled.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Babcock & Wilcox Enterprisesup 8.5%ALSO HIGHER -New Era Energy & Digitalup 8.9% after naming new CFODOWN AFTER EARNINGS -Bakktdown 6.6%Ampco-Pittsburghdown 6.0%ALSO LOWER -LENSARdown 24.2% after terminating Alcon mergerRhythm Pharmaceuticalsdown 5.0% after announcing EMANATE trial substudies did not meet primary endpoints